FDA Clinical Investigator Disqualification List
Review available FDA clinical investigator disqualification records and source status. Distinguish disqualified, restricted and reinstated investigators.
Source availability
Available for screening
232 source records are available in the current dataset.
Records can overlap across lists; this is not a count of unique people or organizations.
- Latest successful check
- Our refresh schedule
- Every 24 hours
Data overview
FDA Clinical Investigator Disqualification Proceedings is published by United States Food and Drug Administration.
The available version contains 232 source records before any name search.
The entity-type breakdown is 232 people.
- Source records
- 232
- Publicly browsable records
- 232
- Entity types present
- 1
Record types and how to read these counts
Records by entity type
- People
- 232
- Other / unspecified
- 0
What these numbers mean
Counts describe this source’s current available records, before any name search. Records can overlap within and across lists. They are not counts of unique entities.
Publicly browsable records are the portion available in the public directory. A record’s presence does not by itself establish an active sanction.
Organizations include companies and other bodies. Other / unspecified means the source record has no more specific supported type.
What this source covers
The complete FDA table includes disqualified investigators, restricted agreements, reinstated investigators, removed restrictions and proceedings that did not result in disqualification. It is not an inspection-results database, a financial sanctions list or a list of people uniformly banned from clinical work.
Distinguish the action from its current effect
Compare the official FDA record ID and the current status. Totally Restricted is FDA’s historical wording for disqualification; Restricted means the investigator remains eligible subject to an agreement. Reinstated, restrictions-removed, not-disqualified and adequate-assurance records are retained as history and excluded from current restriction matching. Original proceedings and status dates remain distinct; no legal start or end date is invented.
- Read the stated action type and procedural status.
- Check the decision, dates and later amendments.
- Keep different orders about the same named party distinct.
FDA Clinical Investigator Disqualification Proceedings records
- Corbett III, Bernard A., MDFDA records disqualification of the clinical investigator Corbett III, Bernard A., MD on 7 Aug 2014.PersonClinical Investigators—Disqualification Proceedings
- Calenoff, Emanuel, MDFDA records disqualification of the clinical investigator Calenoff, Emanuel, MD on 18 Dec 2015.PersonClinical Investigators—Disqualification Proceedings
- Bilezikian, John P., MDFDA records a not-disqualified outcome for the clinical investigator Bilezikian, John P., MD on 27 Nov 2015. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Marquez, Farid, MDFDA records disqualification of the clinical investigator Marquez, Farid, MD on 6 Aug 2015.PersonClinical Investigators—Disqualification Proceedings
- Valdes, Martin, MDFDA records disqualification of the clinical investigator Valdes, Martin, MD on 5 Sep 2024.PersonClinical Investigators—Disqualification Proceedings
- Arata, MD, Michael A.FDA records disqualification of the clinical investigator Arata, MD, Michael A. on 21 May 2018.PersonClinical Investigators—Disqualification Proceedings
- Lichty, Charles P., MDFDA records disqualification of the clinical investigator Lichty, Charles P., MD on 23 Dec 2016.PersonClinical Investigators—Disqualification Proceedings
- Giron, Angela M., MDFDA records disqualification of the clinical investigator Giron, Angela M., MD on 12 Feb 2026.PersonClinical Investigators—Disqualification Proceedings
- Baker, James, MDFDA records disqualification of the clinical investigator Baker, James, MD on 1 May 2018.PersonClinical Investigators—Disqualification Proceedings
- Razzaque, Naveed M.D.FDA reports that the clinical-investigator restrictions were removed for Razzaque, Naveed M.D. on 7 Apr 2025. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Abruzzi, Jr., William A., MDFDA records disqualification of the clinical investigator Abruzzi, Jr., William A., MD on 31 Aug 1966.PersonClinical Investigators—Disqualification Proceedings
- Achreja, Manjeet Kaur, MDFDA records disqualification of the clinical investigator Achreja, Manjeet Kaur, MD on 24 Apr 2008.PersonClinical Investigators—Disqualification Proceedings
- Agus, Bertrand, MDFDA records disqualification of the clinical investigator Agus, Bertrand, MD on 12 Feb 2008.PersonClinical Investigators—Disqualification Proceedings
- Alexander, Elmore, DOFDA records disqualification of the clinical investigator Alexander, Elmore, DO on 15 Aug 2013.PersonClinical Investigators—Disqualification Proceedings
- Ali, Nayab, MDFDA reports that the clinical-investigator restrictions were removed for Ali, Nayab, MD on 23 Jun 1986. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Allbritton, Allan R.,FDA records disqualification of the clinical investigator Allbritton, Allan R., on 24 Jan 1997.PersonClinical Investigators—Disqualification Proceedings
- Allen, Brady L., MDFDA records disqualification of the clinical investigator Allen, Brady L., MD on 11 Dec 1990.PersonClinical Investigators—Disqualification Proceedings
- Allman, Richard M., MDFDA reports that the clinical-investigator restrictions were removed for Allman, Richard M., MD on 1 Sep 2002. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Anderson, Roger D., MDFDA records disqualification of the clinical investigator Anderson, Roger D., MD on 10 Jan 2005.PersonClinical Investigators—Disqualification Proceedings
- Aronow, Wilbert S., MDFDA records a totally restricted clinical-investigator outcome Aronow, Wilbert S., MD on 28 Oct 1982.PersonClinical Investigators—Disqualification Proceedings
- Aroonsakul, Chaovanee, MDFDA records disqualification of the clinical investigator Aroonsakul, Chaovanee, MD on 16 Oct 1991.PersonClinical Investigators—Disqualification Proceedings
- Balin, Howard, MDFDA records disqualification of the clinical investigator Balin, Howard, MD on 19 Mar 1975.PersonClinical Investigators—Disqualification Proceedings
- Baratta, Vincent J, MDFDA records disqualification of the clinical investigator Baratta, Vincent J, MD on 13 Nov 1985.PersonClinical Investigators—Disqualification Proceedings
- Batshaw, Mark L., MDFDA reports that the clinical-investigator restrictions were removed for Batshaw, Mark L., MD on 1 Oct 2007. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Bazo, Albert J., MDFDA records restrictions on the clinical investigator Bazo, Albert J., MD on 4 Nov 1981.PersonClinical Investigators—Disqualification Proceedings
- Bender, Sheldon R., MDFDA records disqualification of the clinical investigator Bender, Sheldon R., MD on 17 Feb 1969.PersonClinical Investigators—Disqualification Proceedings
- Berger, Daniel S., MDFDA reports that the clinical-investigator restrictions were removed for Berger, Daniel S., MD on 10 Sep 2014. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Berger, Michael Dean, MDFDA records disqualification of the clinical investigator Berger, Michael Dean, MD on 20 Jun 2014.PersonClinical Investigators—Disqualification Proceedings
- Bigg, Daniel, MDFDA records disqualification of the clinical investigator Bigg, Daniel, MD on 18 May 2007.PersonClinical Investigators—Disqualification Proceedings
- Blunck, Jr., Carl E., MDFDA records disqualification of the clinical investigator Blunck, Jr., Carl E., MD on 7 Jul 1979.PersonClinical Investigators—Disqualification Proceedings
Screen customers against the FDA Clinical Investigator Disqualification Proceedings
Start free250 free live screenings • One lifetime allowance • API + dashboard • No credit card
Questions about US FDA Clinical Investigator Disqualification Proceedings
Does an FDA investigator listing mean the person is disqualified?
No. Read FDA's stated status and the linked case documents. The database covers past and current proceedings. It includes people who were disqualified, people working under a restricted agreement, people later reinstated, and cases that did not lead to a ban. These outcomes are not the same. A restricted investigator may still receive investigational products if the agreement allows it. FDA's old phrase “totally restricted” means disqualified, rather than the less severe restricted status. “Restrictions removed” means the agreement's limits no longer apply. Check that the entry concerns the person you mean and that its status still applies. An old case alone does not prove a current ban. This database is separate from the FDA drug-product debarment list. Read the publisher’s FDA Clinical Investigator Disqualification Proceedings guidance.
Who publishes US FDA Clinical Investigator Disqualification Proceedings?
The catalog identifies US Food and Drug Administration as the publisher in United States. Open the publisher reference. SanctionsKit’s source profile is separate from that publisher’s original records and notices.
Can I select US FDA Clinical Investigator Disqualification Proceedings for screening?
The current source snapshot marks US FDA Clinical Investigator Disqualification Proceedings as available for screening. Select its source ID, us-fda-restricted, when your policy requires it. Check availability again when you run a request. This status does not by itself grant public browsing or export rights.
Can I browse current US FDA Clinical Investigator Disqualification Proceedings records here?
Current public records from US FDA Clinical Investigator Disqualification Proceedings can be browsed here. The current source contains 232 records. This counts source records, not distinct people, companies or assets. An empty name search is not a completed screening check.
May I reuse or export US FDA Clinical Investigator Disqualification Proceedings records?
Access to US FDA Clinical Investigator Disqualification Proceedings does not grant every right to copy, export or redistribute it. Read the source reuse terms and the attribution notice for the version you use. A public record page or working screening integration is not an export permission. Follow the conditions that apply to your intended use.
Continue exploring
Source discovery reference: OpenSanctions source catalog, captured . Import and record counts above come from SanctionsKit.